| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 99 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 96 |
| 2 | TACROLIMUS OINTMENT 0.1% | 96 |
| 3 | MYCOPHENOLATE MOFETIL | 68 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 68 |
| 5 | PREDNISOLONE | 50 |
| 6 | PREDNISOLONE ORAL | 50 |
| 7 | PREDNISOLONE ORAL SOLUTION | 50 |
| 8 | PAZOPANIB HYDROCHLORIDE | 41 |
| 9 | METHYLPREDNISOLONE | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DENOSUMAB-BMWO | 1 | 0.0303 |
| 1 | THALLOUS CHLORIDE, TL 201 | 1 | 0.0196 |
| 2 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 3 | INTERLEUKIN-10 | 3 | 0.0084 |
| 4 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 5 | IBRITUMOMAB TIUXETAN | 4 | 0.0026 |
| 6 | SOTALOL HYDROCHLORIDE TABLES AF | 4 | 0.0016 |
| 7 | SOTALOL HYDROCHLORIDE TABLETS AF | 4 | 0.0016 |
| 8 | PAZOPANIB HYDROCHLORIDE | 41 | 0.0015 |
| 9 | LAROTRECTINIB | 1 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 23 | 0.0011 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 4 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 5 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 8 | Microtubule Inhibitor [EPC] | 31 | 0.0002 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |